🟢 Nuvation Bio is trading 5% up in pre-market — catalyst remains unclear

Nuvation Bio is trading at $4.80, up 5.03% in pre-market; no confirmed company-specific announcement explains the rise.

• A November 4, 2026, third-quarter results and business-update call was previously announced, but it does not establish the cause of this move.
• Major U.S. indices are modestly higher in the supplied market context, but none is up more than 0.5%; available evidence does not confirm a broader-market explanation.
• The catalyst and pre-market activity level remain unclear.